Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
CD Genomics logo — We are aiming at providing the research community with high...

CD Genomics

We are aiming at providing the research community with high quality Next Generation Seq and Long Read Seq services.

United States United States 7 employees Biotechnology

General Information

Company Name CD Genomics
Location United States United States +1
Employees 7
Industries Biotechnology
Social

Get notified when CD Genomics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About CD Genomics

CD Genomics is a biotechnology startup based in the United States. The company's slogan emphasizes its commitment to providing high-quality Next Generation Sequencing and Long Read Seq services to the research community. Since its establishment in 2007, CD Genomics has expanded its offerings to include molecular biology research and development services, becoming a key player in sequencing, microarray analysis, library construction, and genotyping. With an extensive technology platform that covers mainstream NGS and microarray instruments such as Illumina HiSeq2000/2500, Illumia Miseq, Ion Torrent PGM, PacBio RS, and ABI 3730/3730XL analyzers, CD Genomics has gained the trust of clients from more than 50 countries and districts. The company's focus on professional service and client satisfaction has contributed to its success in serving pharmaceutical and biotech companies, academia, and government agencies. While specific details about the company's last investment and investors are not available, CD Genomics continues to address the increasing demand for its services by leveraging its expertise and experience garnered over nearly a decade. As it moves forward, the company is poised to play an essential role in driving advancements in biotechnology and contributing to the research community's needs for reliable sequencing and array services.

Taxonomy: Next Generation Sequencing, Microarray Analysis, Molecular Biology Research, Library Construction, Genotyping, Bioinformatics, High Throughput Sequencing, Long Read Sequencing, Pharmaceutical Services, Biotech Services, Academic Research Support, NGS Instruments, Bioinformaticians, Technology Platform, Molecular Biology Services

No funding data available for CD Genomics yet.

Get notified when CD Genomics raises funding

CD Genomics Alternatives & Competitors

CD Genomics vs
SeqWright
SeqWright United States

Pioneering the future of nucleic acid sequencing with over 17 years of unmatched quality and customi...

7 employees
Life Sciences
CD Genomics vs
BGI Genomics
BGI Genomics

BGI Genomics, based in China, is the world’s leading provider of genetic tests and sequencing servic...

2142 employees
Biotechnology, Health Care
CD Genomics vs
Gene+
Gene+ China

Omics for better health

Series B
92 employees
Biotechnology

FAQ About CD Genomics

We are aiming at providing the research community with high quality Next Generation Seq and Long Read Seq services.
CD Genomics is headquartered in United States.
CD Genomics operates in the following industries: Biotechnology.
CD Genomics has approximately 7 employees.
Top alternatives and competitors to CD Genomics include SeqWright, BGI Genomics, Gene+, Bio Basic Inc., EDX Medical Group. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
CD Genomics and SeqWright are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors CD Genomics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy